SCHEMBL17875952

SCHEMBL17875952

O=S1(=O)Cc2cc(-c3cccc4oc5ccccc5c34)ccc2-c2cc(-c3cc(-c4ccccc4)cc(-c4ccccc4)c3)ccc2C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.37
PLA2G4A P47712 4/20 0.37
PLA2G10 O15496 1/20 0.35
PRKDC P78527 3/20 0.33
TDP2 O95551 1/20 0.33
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MEN1 O00255 1/20 0.32
APAF1 O14727 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
THRB P10828 1/20 0.32
XBP1 P17861 1/20 0.32
PTBP1 P26599 1/20 0.32
HTT P42858 1/20 0.32
GALK1 P51570 1/20 0.32
BLM P54132 1/20 0.32
SMAD3 P84022 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875958 1.00 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10PRKDCTDP2
SCHEMBL17876004 0.96 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10PRKDCNPC1
SCHEMBL17875951 0.93 ALOX5 (0.35) PLA2G2APLA2G4APRKDCNPC1RAB9A
SCHEMBL17875956 0.91 PRKDC (0.32) PLA2G2APLA2G4APLA2G10PRKDCMAPT
SCHEMBL17875971 0.91 PRKDC (0.32) PLA2G2APLA2G4APLA2G10PRKDCMAPT
SCHEMBL17875935 0.90 PRKDC (0.37) PLA2G2APLA2G4APRKDCNPC1RAB9A
SCHEMBL17875942 0.90 HSP90AA1 (0.35) PLA2G2APLA2G4APLA2G10PRKDCNPC1
SCHEMBL17875950 0.90 PRKDC (0.37) PLA2G2APLA2G4APRKDCNPC1RAB9A
SCHEMBL17875949 0.90 HSP90AA1 (0.35) PLA2G2APLA2G4APLA2G10PRKDCNPC1
SCHEMBL17875953 0.89 CYP11B1 (0.39) PRKDCTDP2MEN1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 PLA2G2A 4359/4885PLA2G4A 4087/4885PLA2G10 4067/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 PLA2G2A 4359/4885PLA2G4A 4087/4885PLA2G10 4067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.